|Articles|February 10, 2023
SCOPE 2023: Beat AML Master Trial Successes
Author(s)Lisa Henderson
Len Rosenberg, head of clinical operations at Beat AML, discusses the outcome of his company's study, which was four years in the making.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, updates the public on the trial results (which he was a lead author of) and how the use of precision medicine guidelines played a role.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
2
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
3
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
4
When the Slack Runs Out: AI and the CRO Operating Model
5